Comparative oncology today.
The value of comparative oncology has been increasingly recognized in the field of cancer research, including the identification of cancer-associated genes; the study of environmental risk factors, tumor biology, and progression; and, perhaps most importantly, the evaluation of novel cancer therapeutics. The fruits of this effort are expected to be the creation of better and more specific drugs to benefit veterinary and human patients who have cancer. The state of the comparative oncology field is outlined in this article, with an emphasis on cancer in dogs.
Paoloni
Melissa C
MC
Comparative Oncology Program, National Cancer Institute, National Institutes of Health, 37 Convent Drive, Room 2144, Bethesda, MD 20892, USA.
Khanna
Chand
C
D000818:Animals; D002986:Clinical Trials as Topic; D004283:Dog Diseases / Q000235:genetics*; D004285:Dogs; D008495:Medical Oncology / Q000639:trends; D009369:Neoplasms / Q000235:genetics / Q000662:veterinary*; D013045:Species Specificity; D014730:Veterinary Medicine / Q000639:trends